Ir para o conteúdo principal

Infelizmente, não oferecemos suporte total ao seu navegador. Se for possível, atualize para uma versão mais recente ou use o Mozilla Firefox, o Microsoft Edge, o Google Chrome ou o Safari 14 ou mais recente. Se não conseguir e precisar de suporte, envie seu feedback.

Gostaríamos de receber seu feedback sobre essa nova experiência.Diga-nos sua opinião abre em uma nova guia/janela

Elsevier
Publique conosco
Connect

Novel Coronavirus Information Center

27 de janeiro de 2020

Close-up of coronavirus molecules

Elsevier’s free health and medical research on the novel coronavirus (SARS-CoV-2) and COVID-19

Last updated 7/25/2023

Welcome to Elsevier's Novel Coronavirus Information Center. Here you will find expert, curated information for the research and health community on SARS-CoV-2 and COVID-19.

Note: In line with WHO ending the Public Health Emergency of International Concern for COVID-19 on 5 May 2023, Covid-19-related content published up until July 2023 will remain freely available for both reading and text and data mining.

Scroll down to find sections on:

  • Clinical resources

  • Mental health

  • Access to research

  • Vaccines & drug discovery

  • Public health

For researchers

In the Research section, you can access COVID-19-related articles from Elsevier, Cell Press and The Lancet, along with COVID-19-related book chapters, that we made freely available on ScienceDirect  abre em uma nova guia/janeladuring the duration of the crisis. We also made this collection available as a machine-readable corpus to enable advanced discovery methods and identification of patterns and relationships in data (text and data mining). These articles are also available to download over FTP with rights for full text and data mining, re-use and analyses for as long as needed.

  • Server address: coronacontent.np.elsst.com

  • Protocol: sftp (SSH File Transfer Protocol)

  • Username: public

  • Password: beat_corona

You will need to use FTP client software such as Cyberduck abre em uma nova guia/janela or WinSCP abre em uma nova guia/janela to access the FTP server.

We shared daily updates to this corpus with the Allen Institute for inclusion in the multi-publisher CORD-19 dataset abre em uma nova guia/janela.

Additionally, we collaborated with the World Health Organization (WHO) and the National Library of Medicine (NLM) to make this content rapidly and freely available to global research and health communities as well as the general public from Pubmed Central (PMC) at PMC COVID-19 Collection abre em uma nova guia/janela, including for text and data mining via the PMC Open Access Subset abre em uma nova guia/janela.

In line with WHO ending the Public Health Emergency of International Concern for COVID-19 on 5 May 2023, Covid-19-related content published up until July 2023 will remain freely available for both reading and text and data mining. This content is available both via Elsevier’s websites, as well as via PMC whom we allow to retain this content in perpetuity under the terms of the original licenses.

For clinicians

Under the Clinical information tab, you will find evidence-based skill guides and care plans for treatment, safety and patient education, along with emergency prepared resources.

For patients

In the Patient Resources section, you can find our 3D4Medical coronavirus video, resources from the CDC and WHO, and information about Elsevier's Patient Access Program for research.

Introduction

Margaret Trexler Hessen, MD, Director, Point of Care, Elsevier

When we created this resource in January 2020, we anticipated “an explosion of clinical and epidemiological information and research,” and we have certainly seen that. Our goal was to open whatever resources we could to help public health authorities, researchers and clinicians contain and manage this disease. We continue to provide regularly updated resources from Elsevier's content and experts. Our resources span scientific and medical journals, educational offerings — including our clinically focused COVID-19 Healthcare Hub abre em uma nova guia/janela — and podcast interviews with internationally-recognized experts. We are also participating in the Education Continuity License abre em uma nova guia/janela from the Copyright Clearance Center, allowing the use of publishers’ materials in distance-learning models and other uses as required by the pandemic at no cost to the user. In addition, Elsevier has from the beginning enabled full text and data mining of this growing body of knowledge through channels such as the NIH’s PubMed Central and the WHO database for free and without copyright limitations. Elsevier, Cell Press and The Lancet have also joined the signatories on the Wellcome Trust’s Statement abre em uma nova guia/janela, designed to ensure that research findings and data relevant to this outbreak are shared rapidly and openly to inform the public health response and help save lives. Elsevier has been pleased and proud to provide these resources to more than 2 million users. If you're looking for information on our other free and low-cost access programs, including resources for patients and caregivers, you can find that here.

Clinical information

In this section, you can find resources from Elsevier Clinical Solutions, including guidance from ClinicalKey, Clinical Skills for Nursing, Interprofessional care plans and Patient Education resources. Gain access to our latest evidence-based practices and resources for COVID-19, covering topics from symptom management to diagnosis, treatment and ongoing wellness. These resources include Clinical Overviews on ClinicalKey — easy-to-scan clinically focused medical topic summaries designed to match the clinician workflow. Elsevier's Point-of-Care Editorial team develops them through a process that includes review and revision by a medical editor; peer reviews performed by subject matter experts; a production review to ensure consistency in style, grammar, and punctuation; and a final evaluation by the editor-in-chief.

For more information, visit Elsevier's COVID-19 Healthcare Hub(abre em uma nova guia/janela)

Elsevier has created a dedicated COVID-19 Healthcare Hub for clinicians in India.

Vaccine guidelines

You can find more information on vaccines in Elsevier's COVID-19 Healthcare Hub Vaccine Toolkit: abre em uma nova guia/janela

Podcast series

In Elsevier's podcast series for frontline clinicians and providers, experts share their insights into the mode of transmission and pathophysiology of the virus, how medical informatics and telemedicine are used to manage the pandemic, and best practices for emergency nursing crisis preparedness.

Elsevier-podvcast-series-image

Mental and behavioral health

With the fear and uncertainty brought on by the pandemic — and calls for social distancing — many people are experiencing increased stress, anxiety and depression. Our evidence-based patient education resources support professional practice guidelines, presenting information in a way that is easy to understand and actionable.

Visit Elsevier's Mental Healthcare Hub(abre em uma nova guia/janela)

Anxiety resources

Elsevier has created this anxiety screening tool abre em uma nova guia/janela as part of our COVID-19 resources for patients, clinicians and the public. It's designed for individuals age 13 years and older. For all others, please talk to your healthcare team about you or your child’s questions and concerns. More resources:

Watch a video on Managing anxiety adult abre em uma nova guia/janela

Book chapters and peer-reviewed articles from Elsevier journals

Journal articles

Depression resources

Elsevier has created this depression screening tool abre em uma nova guia/janela as part of our COVID-19 resources for patients, clinicians and the public. It's designed for individuals age 18 years and older. For all others, please talk to your healthcare team about you or your child’s questions and concerns.

Watch a video on Mental Health Depression abre em uma nova guia/janela

Book chapters and peer-reviewed articles from Elsevier journals

Journal articles

Research

Related articles freely available on ScienceDirect

Elsevier made coronavirus-related articles and book chapters freely available on ScienceDirect abre em uma nova guia/janela, commencing in February 2020, and lasting for the duration of the crisis. We also made this collection available as a machine-readable corpus to enable advanced discovery methods and identification of patterns and relationships in data (text and data mining).

Additionally, we collaborated with the World Health Organization (WHO) and the National Library of Medicine (NLM) to make this content rapidly and freely available to global research and health communities as well as the general public from Pubmed Central (PMC) at PMC COVID-19 Collection, including for text and data mining via the PMC Open Access Subset abre em uma nova guia/janela.

In line with WHO ending the Public Health Emergency of International Concern for COVID-19 on 5 May 2023, Covid-19-related content published up until July 2023 will remain freely available for both reading and text and data mining. This content is available both via Elsevier’s websites, as well as via PMC whom we allow to retain this content in perpetuity under the terms of the original licenses.

Additional resources include:

Search for COVID-19 research on ScienceDirect(abre em uma nova guia/janela)

Early-stage research: preprints on SSRN

Rapidly evolving healthcare emergencies necessitate the quick dissemination of research. The growing role of preprints, or early-stage research, was acknowledged in the Ebola and Zika virus outbreaks as a way of “accelerating the dissemination of scientific findings to support responses to infectious disease outbreaks. abre em uma nova guia/janela” SSRN abre em uma nova guia/janela , Elsevier’s platform for the rapid worldwide dissemination of early-stage research, is committed to making authors' coronavirus related research abre em uma nova guia/janela available immediately. Research on SSRN is free to download and upload. It is important to note that these papers have not benefited from the pivotal role of the peer-review process, which validates and improves the quality of final published journal articles.

View coronavirus research on SSRN abre em uma nova guia/janela

View COVID-19 preprints on SSRN(abre em uma nova guia/janela)

Patient resources

عدوى فيروس كورونا المستجد (patient education in Arabic)

عدوى فيروس كورونا المستجد abre em uma nova guia/janela

Usage notice

In January 2020, Elsevier abre em uma nova guia/janela created this online resource center with free information in English and Mandarin on the novel coronavirus (COVID-19).

This Novel Coronavirus Information Center is hosted on Elsevier Connect, the company’s public news and information website.

Elsevier hereby grants permission to make COVID-19-related research that was available on the COVID-19 resource center — including COVID-19-related research content published before July 2023 — immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource center remains active.